Targeted Drug Intervention to Inhibit Cancer Progression in Men on Active Surveillance for Prostate Cancer. Therapeutics in Active Prostate Cancer Surveillance (TAPS01)
Phase of Trial: Phase II
Latest Information Update: 11 Jun 2018
At a glance
- Drugs Apalutamide (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 11 Jun 2018 Status changed from not yet recruiting to recruiting.
- 05 Jun 2018 Planned End Date changed from 27 Apr 2019 to 5 Jun 2020.
- 05 Jun 2018 Planned primary completion date changed from 27 Apr 2019 to 5 Sep 2019.